The methodology for determining the efficacy of antibody-mediated immunity

Journal of Immunological Methods

Volumn 291, Issue 1-2, 2004, Pages 1-10

  Casadevall, Arturo ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Animal models; Antibody; Method; Passive; Protection

Indexed keywords

ANTIBODY; MONOCLONAL ANTIBODY;

ANTIGEN ANTIBODY REACTION; HOST RESISTANCE; HUMAN; HYBRIDOMA; IMMUNITY; METHODOLOGY; MICROORGANISM; NONHUMAN; PRIORITY JOURNAL; REVIEW; THEORETICAL STUDY;

ANIMALS; ANTIBODIES; ANTIBODY FORMATION; BACTERIA; HUMANS; MODELS, IMMUNOLOGICAL; TIME FACTORS;

ANIMALIA;

EID: 4444290709     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2004.04.027     Document Type: Review

References (65)

1. Anderson C.F., Mosser D.M. Cutting edge: biasing immune responses by directing antigen to macrophage Fcγ receptors. J. Immunol. 168:2002;3697
2. Asano Y., Albrecht P., Stagno S., Takahashi M. Potentiation of neutralization of varicella-zoster virus to antibody to immunoglobulin. J. Infect. Dis. 146:1982;524
3. Baker P.J. Regulation of magnitude of antibody response to bacterial polysaccharide antigens by thymus-derived lymphocytes. Infect. Immun. 58:1990;3465
4. Basta M., Van Goor F., Luccioli S., Billings E.M., Vortmeyer A.O., Baranyi L., Szebeni J., Alving C.R., Carroll M.C., Berkower I., Stojilkovic S.S., Metcalfe D.D. F(ab)′(2)-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins. Nat. Med. 2003
5. Beenhouwer D.O., Shapiro S., Feldmesser M., Casadevall A., Scharff M.D. Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans. Infect. Immun. 69:2001;6445
6. Behring E.A., Kitasato S. Ueber das Zustandekommen der Diptherie-Immunität und der Tetanus-Immunität bei Thieren. Deutsch. Med. Woch. 49:1890;1113
7. Bretscher P.A. An hypothesis to explain why cell-mediated immunity alone can contain infections by certain intracellular parasites and how immune class regulation of the response can be subverted. Immunol. Cell Biol. 70:1992;343
8. Briles D.E., Forman C., Crain M. Mouse antibody to phosphocholine can protect mice from infection with mouse-virulent human isolates of Streptococcus pneumoniae. Infect. Immun. 60:1992;1957
9. Casadevall A. Passive antibody administration (immediate immunity) as a specific defense against biological weapons. Emerg. Infect. Dis. 8:2002;833
10. Casadevall A., Pirofski L.A. Antibody-mediated regulation of cellular immunity and the inflammatory response. Trends Immunol. 24:2003;474
11. Casadevall A., Scharff M.D. "Serum Therapy" revisited: animal models of infection and the development of passive antibody therapy. Antimicrob. Agents Chemother. 38:1994;1695
12. Clynes R., Maizes J.S., Guinamard R., Ono M., Takai T., Ravetch J.V. Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors. J. Exp. Med. 189:1999;179
13. Connolly S.E., Thanassi D.G., Benach J.L. Generation of a complement-independent bactericidal IgM against a relapsing fever Borrelia. J. Immunol. 172:2004;1191
14. Dromer F., Perrone C., Barge J., Vilde J.L., Yeni P. Role of IgG and complement component C5 in the inital course of experimental cryptococcosis. Clin. Exp. Immunol. 78:1989;412
15. Eisenstein T.K., Sultzer B.M. Immunity to Salmonella infection. Adv. Exp. Med. Biol. 162:1983;261
16. Eisenstein T.K., Millar L.M., Sultzer B.M. Immunity to infection with Salmonella typhimurium: mouse-strain differences in vaccine- and serum-mediated protection. J. Infect. Dis. 150:1984;425
17. Eis-Hubinger A.M., Schmidt D.S., Schneweis K.E. Anti-glycoprotein b monoclonal antibody protects T cell-dependent mice against herpes simplex virus infection by inhibition of virus replication at the inoculated mucous membranes. J. Gen. Virol. 74:1993;379
18. Elzer P.H., Jacobson R.H., Jones S.M., Nielsen K.H., Douglas J.T., Winter A.J. Antibody-mediated protection against Brucella abortus in BALB/c mice at successive periods after infection: variation between virulent strain 2308 and attenuated vaccine strain 19. Immunology. 82:1994;651
19. Feldmesser M., Mednick A., Casadevall A. Antibody-mediated protection in murine Cryptococcus neoformans infection is associated with subtle pleotrophic effects on the cytokine and leukocyte response. Infect. Immun. 70:2002;1571
20. Felton L.D. The units of protective antibody in anti-pneumococcus serum and antibody solution. J. Infect. Dis. 43:1928;531
21. Felton L.D. The concentration of anti-pneumococcus serum. JAMA. 94:1930;1893
22. Flavell D.J., Cooper S., Okayama K., Emery L., Flavell S.U. Comparison of the performance of anti-CD7 and anti-CD38 bispecific antibodies and immunotoxins for the delivery of saporin to a human T-cell acute lymphoblastic leukemia cell line. Hematol. Oncol. 13:1995;185
23. Forghani B., Ni L., Grose C. Neutralization epitope of the varicella-zoster virus gH:gL glycoprotein complex. Virology. 199:1994;458
24. Fothergill L.D., Wright J. Influenzal meningitis: the relation of age incidence to the bactericidal power of blood against the causal organism. J. Immunol. 24:1933;273
25. Gigliotti F., Insel R.A. Protection from infection with Haemophilus influenzae Type b by monoclonal antibody to the capsule. J. Infect. Dis. 146:1992;249
26. Gigliotti F., Haidaris C.G., Wright T.W., Harmsen A.G. Passive intranasal monoclonal antibody prophylaxis against murine Pneumocystis carinii pneumonia. Infect. Immun. 70:2002;1069
27. Glatman-Freedman A., Casadevall A. Serum therapy for tuberculosis revisited: a reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis. Clin. Microbiol. Rev. 11:1998;514
28. Goodner K., Horsfall F.L. The protective action of Type I antipneumococcus serum in mice: I. Quantitative aspects of the mouse protection test. J. Exp. Med. 62:1935;359
29. Granoff D.M. Assessing efficacy of Haemophilus influenzae type b combination vaccines. Clin. Infect. Dis. 33(Suppl. 4):2001;S278
30. Han Y., Cutler J.E. Antibody response that protects against disseminated candidiasis. Infect. Immun. 63:1995;2714
31. Hasenkrug K.J., Brooks D.M., Chesebro B. Passive immunotherapy for retroviral disease: influence of major histocompatibility complex type and T-cell responsiveness. Proc. Natl. Acad. Sci. 92:1995;10492
32. Hirsch R.L., Griffin D.E., Johnson R.T. Interactions between immune cells and antibody in protection from fatal Sindbis virus encephalitis. Infect. Immun. 23:1979;320
33. Horsfall F.L. Jr., Goodner K., MacLeod C.M., Harris A.H. Antipneumococcus rabbit serum as a therapeutic agent in lobar pneumonia. JAMA. 18:1937;1483
34. Kozel T.R., MacGill R.S., Percival A., Zhou Q. Biological activities of naturally occurring antibodies reactive with Candida albicans Mannan. Infect. Immun. 72:2004;209
35. Lagrange P.H., Mackaness G.B., Miller T.E. Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide. J. Exp. Med. 139:1974;1529
36. Lang A.B., Cryz S.J., Schurch U., Ganss M.T., Bruderer U. Immunotherapy with human monoclonal antibodies. J. Immunol. 151:1993;466
37. Lieberman M.M., Frank W.J., Brady A.V. Protective mechanism of the immune response to a ribosomal vaccine from Pseudomonas aeruginosa: II. In vitro bactericidal and opsonophagocytic studies with specific antiserum. J. Surg. Res. 44:1988;251
38. Lowell G.H., MacDermott R.P., Summeers P.L., Reeder A.A., Bertovich M.J., Formal S.B. Antibody-dependent cell-mediated antibacterial activity: K lymphocytes, monocytes, and granulocytes are effective against shigella. J. Immunol. 125:1980;2778
39. Mackaness G.B. Cellular immunity and the parasite. Adv. Exp. Med Biol. 93:1977;65
40. Marinets A., Zhang T., Guillen N., Gounon P., Bohle B., Vollmann U., Scheiner O., Wiedermann G., Stanley S.L., Duchene M. Protection against invasive amebiasis by a single monoclonal antibody directed against a lipophosphoglycan antigen localized on the surface of Entamoeba histolytica. J. Exp. Med. 186:1997;1557
41. Miki K., Mackaness G.B. The passive transfer of acquired resistance to Listeria monocytogenes. J. Exp. Med. 120:1964;93
42. Mukherjee J., Scharff M.D., Casadevall A. Variable efficacy of passive antibody administration against diverse Cryptococcus neoformans strains. Infect. Immun. 63:1995;3353
43. Parish C.R. The relationship between humoral and cell-mediated immunity. Transplant. Rev. 13:1972;35
44. Parker S.J., Sadlon T.A., Gordon D.L. Enhancement of NK cell-mediated antibody-dependent lysis of recombinant gp120-coated CD4 cells by complement. J. Infect. Dis. 171:1995;186
45. Peeling R., Maclean I.W., Brunham R.C. In vitro neutralization of Chlamydia trachomatis with monoclonal antibody to an epitope on the major outer membrane protein. Infect. Immun. 46:1984;484
46. Picard C., Puel A., Bustamante J., Ku C.L., Casanova J.L. Primary immunodeficiencies associated with pneumococcal disease. Curr. Opin. Allergy Clin. Immunol. 3:2003;451
47. Pirofski L. Polysaccharides, mimotopes and vaccines for fungal and encapsulated pathogens. Trends Microbiol. 9:2001;445
48. Prasad N.K., Papoff G., Zeuner A., Bonnin E., Kazatchkine M.D., Ruberti G., Kaveri S.V. Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway. J. Immunol. 161:1998;3781
49. Ravetch J.V., Lanier L.L. Immune inhibitory receptors. Science. 290:2000;84
50. Rhinehart-Jones T.R., Fortier A.H., Elkins K.L. Transfer of immunity against lethal murine Francisella infection by specific antibody depends on host gamma interferon and T cells. Infect. Immun. 62:1994;3129
51. Rivera J., Mukherjee J., Weiss L.M., Casadevall A. Antibody efficacy in murine pulmonary Cryptococcus neoformans infection: a role for nitric oxide. J. Immunol. 168:2002;3419
52. Robbins J.B., Schneerson R., Szu S.C. Perspective: Hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum. J. Infect. Dis. 171:1995;1387
53. Samulsson A., Towers T.L., Ravetch J.V. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science. 291:2001;484
54. Sato H., Albrecht P., Krugman S., Ennis F.A. Sensitive neutralization test for rubella antibody. J. Clin. Microbiol. 9:1979;259
55. Sullivan N.J. Antibody-mediated enhancement of viral disease. Curr. Top. Microbiol. Immunol. 260:2001;145
56. Szomolanyi-Tsuda E., Welsh R.M. T cell-independent antibody-mediated clearance of polyoma virus in T cell-deficient mice. J. Exp. Med. 183:1996;403
57. Taborda C.P., Casadevall A. Immunoglobulin M efficacy against Cryptococcus neoformans: mechanism, dose dependence and prozone-like effects in passive protection experiments. J. Immunol. 66:2001;2100
58. Taborda C.P., Rivera J., Zaragoza O., Casadevall A. More is not necessarily better: 'prozone-like' effects in passive immunization with immunoglobulin G. J. Immunol. 170:2003;3621-3630
59. Tzianabos A.O., Onderdonk A.b., Zaleznik D.F., Smith R.S., Kasper D.L. Structural characteristics of polysaccharides that induce protection against intra-abdominal abscess formation. Infect. Immun. 62:1994;4881
60. Vecchiarelli A. Immunoregulation by capsular components of Cryptococcus neoformans. Med. Mycol. 38:2000;407
61. Wadhwa M., Meager A., Dilger P., Bird C., Dolman C., Das R.G., Thorpe R. Neutralizing antibodies to granulocyte-macrophage colony-stimulating factor, interleukin-1alpha and interferon-alpha but not other cytokines in human immunoglobulin preparations. Immunology. 99:2000;113
62. Winkelstein J.A., Swift A.J. Host defense against the pneumococcus in T-lymphocyte deficient, nude mice. Infect. Immun. 12:1975;1222
63. Winslow G.M., Yager E., Shilo K., Volk E., Reilly A., Chu F.K. Antibody-mediated elimination of the obligate intracellular bacterial pathogen Erhlichia chaffeensis during active infection. Infect. Immun. 68:2000;2187
64. Yuan R., Casadevall A., Spira G., Scharff M.D. Isotype switching from IgG3 to IgG1 converts a non-protective murine antibody to C. neoformans into a protective antibody. J. Immunol. 154:1995;1810
65. Yuan R., Casadevall A., Oh J., Scharff M.D. T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice. Proc. Natl. Acad. Sci. 94:1997;2483